Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

April 21, 2023

Study Completion Date

November 1, 2023

Conditions
Breast CancerAdherence, MedicationSide Effect
Interventions
BEHAVIORAL

BETA-Text text messaging intervention

Patients in the text messaging arm will receive daily, weekly, and monthly text messages. The daily message asks whether or not the patient has taken their breast cancer medication. The weekly message asks about any side effects and their severity. The monthly text message asks about any barriers that the patient might be experiencing. Concerning responses to any of the text messages will prompt contact from the office of the treating physician.

Trial Locations (1)

06511

Yale Cancer Center, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT03949270 - Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer | Biotech Hunter | Biotech Hunter